Immune cell engineeringcancerautoimmunityinfectionIL-2CD19 CAR
…Background Immune cell engineering has the potential to revolutionize the treatment of many pathol…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,321–1,380 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
endovascular catheter rewarming1fibrinolytics1host directed treatments1iTBS1immuno-chemotherapy1inhaled aminoglycosides1insulin regimen1keratoplasty1language therapy1neuropsychology testing1pTVE1percutaneous transluminal angioplasty with stenting1poRT1post-acute stroke rehabilitation1prophylactic compression hosiery1repetitive peripheral magnetic stimulation1respiratory specialist review1secondary prevention medication regimens1sinonasal surgery1spirometry1tenodesis1therapeutic vaccination1Angiogenic therapy1Anti-H.pylori treatment1Antiresorptive or anabolic therapy1Autologous serum eye drops1B cell therapy1BACE1BGM1BiTE therapy1Biological treatments1Bronchial Thermoplasty1C-ion RT1CAH1CBCT-NB1CD19-targeting CAR T cell therapy1CIO1CKM1CNI therapy1Capsule sponge1Collagen supplementation1Complete endovascular sinus occlusion1D2N1DAPTs1Direct percutaneous embolisation1Double lung transplantation1EAE1EBAC1ECMO1ELPS1EPC1ERAI1ESG1ESP-block1EV–Pem1EXER+RPW1EmOC1Endoscopic neurotomy1FB DOTS1FS-LASIK1
Articles mentioning treatments
7,227 articles · page 486 of 603immunotherapyBreast CancerTME
…Background Despite advances in immunotherapy, durable patient responses remain a minority. This is partly du…
multispecific antibody treatmentsmonospecific antibody checkpoint inhibitors
…r cell types to enhance clinical outcomes, often in the form of multispecific antibody treatments (‘multispecifics’). Many of these multispecifics target the T c…
CAR T cell therapyhematological cancersPortal
…Background CAR T cell therapy has had a tremendous impact on the treatment of hematological c…
immunotherapyBreast Cancerlung and colon cancer
…ite remarkable results for many patients, the response rate for immunotherapy varies from one patient to the next. While technological advanc…
Fecal microbiota transplantationKAN-004irColitisCentre Hospitalier de l’Université de MontréalKanvas Biosciences
…hich can necessitate immunosuppression and ICI discontinuation. Fecal microbiota transplantation (FMT) has shown promise in treating irColitis, but concerns aro…
anti-PD-1 therapyUniversity of Pittsburgh School of MedicinenivolumabUniversity of PittsburghDietary interventionRelatlimab
…bial alterations to simulate human susceptibility to irAEs upon anti-PD-1 therapy. 3 4 This model faithfully recapitulates human disease in tissu…
anti-programmed cell death ligand-1(PD-L1) therapyNSCLCICI-related pneumonitisNorthwestern UniversityIRP
… and accounting for 35% of ICI-related deaths in patients under anti-programmed cell death ligand-1(PD-L1) therapy. 1 Real-world studies have demonstrated higher incidence rates …
cancer therapyGEH200520GE Healthcaresolid tumorsGEH200521University Medical Center GroningenVanderbilt UniversityGE-269-004
…f therapy mechanism of action and identification of response to cancer therapy. We present results from two phase 1 studies sponsored by GE He…
Immunotherapiescytokine release syndrome
…Background Immunotherapies exhibit class- and target-specific safety challenges, particula…
immunotherapyMD AndersonMD Anderson Cancer Center Institutional Review BoardIV corticosteroidsadvanced urinary cancers
…lly morbid toxicities, occurring in ~1-8% of patients receiving immunotherapy. Prognostic and predictive biomarkers are lacking. We hypothesi…
ChemotherapyECOG Performance StatusRenal Cell CarcinomaMelanomaBladder Cancerurothelial cancersAmerican University of BeirutRCCICIsAUB
…nt predictors of renal IRAEs. As for dermatological IRAEs, only Chemotherapy (p = 0.031) and cancer stage (p=0.006) were significant predict…